COGNITION THERAPEUTICS

Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there are currently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the unique combination of biological expertise around these targets, including proprietary assays that emphasize functional responses and proprietary medicinal chemistry that insures novel, high quality small-molecule drug candidates.

COGNITION THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Life Science Therapeutics

Founded:

2007-01-01

Address:

Pittsburgh, Pennsylvania, United States

Country:

United States

Website Url:

http://www.cogrx.com

Total Employee:

51+

Status:

Active

Contact:

(412)481-2210

Email Addresses:

[email protected]

Total Funding:

157.49 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Sitelinks Search Box Euro

Similar Organizations

reflection-therapeutics-logo

Reflection Therapeutics

Reflection Therapeutics is developing cell therapy technology against neuroinflammation across the board.

invivo-biosystems-logo

InVivo Biosystems

InVivo Biosystems is using alternative, non-mammalian model organisms in early biological and biomedical research.

neuronascent-logo

NeuroNascent

Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.

nereid-therapeutics-logo

Nereid Therapeutics

Nereid Therapeutics is discovering new disease treatments by applying research and technologies in biomolecular condensates.

nuntius-therapeutics-logo

Nuntius Therapeutics

Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies.

neuroglee-therapeutics-logo

Neuroglee Therapeutics

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

nurix-therapeutics-logo

Nurix Therapeutics

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

veralox-therapeutics-logo

Veralox Therapeutics

Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.

viking-therapeutics-logo

Viking Therapeutics

Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.

vodori-logo

Vodori

Vodori provides solutions that simplify how life science companies create, approve, and distribute promotional content.

via-nova-therapeutics-logo

Via Nova Therapeutics

Via Nova Therapeutics is to discover and develop therapeutics for acute and subacute viral infections.

mitochem-therapeutics-logo

MitoChem Therapeutics

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

metabolic-solutions-development-logo

Metabolic Solutions Development

Metabolic Solutions Development develops innovative therapeutics based on a novel pharmacological method to treat type two diabetes.

mobilion-systems-logo

Mobilion Systems

MOBILion Systems specializes in identifying and analyzing challenging molecules that other instruments so far have failed to detect.

leyden-labs-logo

Leyden Labs

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

lipopharma-logo

Lipopharma

Lipopharma is company that designs and develops synthetic bio-active lipids that interact with proteins involved in serious diseases.

lnc-therapeutics-logo

LNC Therapeutics

LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.

abac-therapeutics-logo

ABAC Therapeutics

ABAC Therapeutics (ABAC) develops new targeted antibiotics for patients with severe infections.

autobahn-therapeutics-logo

Autobahn Therapeutics

Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.

aadi-bioscience-logo

Aadi Bioscience

Aadi Bioscience develops a potentially mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases.

abcam-logo

Abcam

An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.

asterias-biotherapeutics-logo

Asterias Biotherapeutics

Asterias Biotherapeutics is a development-stage biotechnology company pioneering the field of regenerative medicine.

acumen-pharmaceuticals-logo

Acumen Pharmaceuticals

Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

engeneic-logo

EnGeneIC

EnGeneIC develops and commercializes the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells.

electrocore-logo

electroCore

ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.

evommune-logo

Evommune

Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines.

epirus-biopharmaceuticals-logo

Epirus Biopharmaceuticals

Epirus Biopharmaceuticals develops biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.

edesa-biotech-logo

Edesa Biotech

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

broad-institute-logo

Broad Institute

The Broad Institute brings together a diverse group of individuals from across its partner institutions to confront biomedical challenges.

bioaegis-therapeutics-logo

BioAegis Therapeutics

BioAegis is developing therapeutics for infectious, inflammatory and degenerative diseases based on the platform of plasma gelsolin.

fluidic-analytics-logo

Fluidic Analytics

Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.

tranquis-therapeutics-logo

Tranquis Therapeutics

Tranquis Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative and aging-related diseases.

tapimmune-logo

TapImmune

TapImmune develops immunotherapeutics to treat cancers, infectious diseases, autoimmune disorders, and transplant tissue rejection.

think-bioscience-logo

Think Bioscience

Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.

thrive-bioscience-logo

Thrive Bioscience

Thrive sells instruments and software that automate with extensive imaging, analytics, and AI manual and stem cell culture.

t3-pharmaceuticals-logo

T3 Pharmaceuticals

T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.

t3d-therapeutics-logo

T3D Therapeutics

T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.

annovis-bio-logo

Annovis Bio

Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.

kyverna-therapeutics-logo

Kyverna Therapeutics

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.

kineta-logo

Kineta

Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

senda-biosciences-logo

Senda Biosciences

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

signum-biosciences-logo

Signum Biosciences

Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.

sonoma-biotherapeutics-logo

Sonoma BioTherapeutics

Sonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.

seranova-bio-logo

Seranova Bio

Seranova Bio develops companion diagnostics or therapeutics to treat autoimmune disease or other autoantibody-driven diseases.

not_available_image

Souvien Therapeutics

Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.

sqz-biotech-logo

SQZ Biotech

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

sharp-edge-labs-logo

Sharp Edge Labs

Sharp Edge Labs is engaged in the development of biosensors for cellular biology research and high-throughput screening.

scioto-biosciences-logo

Scioto Biosciences

Scioto is a developer of Activated Bacterial Therapeutics platform.

hydra-biosciences-logo

Hydra Biosciences

Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.

hui-gene-therapeutics-logo

Hui-Gene Therapeutics

Hui-Gene is focused on R&D for single-gene disorders and has developed pilot pipes in neurodegenerative diseases.

immusoft-logo

Immusoft

Immusoft, a biotechnology company, commercializes technologies that program the human immune system by modifying the DNA in related cells.

immunomic-therapeutics-logo

Immunomic Therapeutics

Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.

iconic-therapeutics-logo

Iconic Therapeutics

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

revolo-biotherapeutics-logo

Revolo Biotherapeutics

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.

imcheck-therapeutics-logo

ImCheck Therapeutics

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

intergalactic-therapeutics-logo

Intergalactic Therapeutics

Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.

ispecimen-logo

iSpecimen

iSpecimen is the marketplace for human biospecimens, providing researchers with the samples they need from the patients they want.

glygenix-therapeutics-logo

GlyGenix Therapeutics

GlyGenix Therapeutics develops therapeutic products for the treatment of cure metabolic disorders.

good-therapeutics-logo

Good Therapeutics

Good Therapeutics develops new technology for self-regulating drugs that will provide a therapeutic activity when, where it is needed.

galera-therapeutics-logo

Galera Therapeutics

Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.

gamma-biosciences-logo

Gamma Biosciences

Gamma Biosciences is a next-generation bioprocessing for advanced therapies by acquiring or investing in high-potential businesses.

garuda-therapeutics-logo

Garuda Therapeutics

Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat severe and life-threatening diseases.

omniome-logo

Omniome

Omniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.

oligomerix-logo

Oligomerix

Oligomerix develops target identification and validation technologies enhancing the drug discovery process for neurodegenerative diseases.

onkure-therapeutics-logo

OnKure Therapeutics

OnKure is a biotechnology company that commercializes a new cancer therapy based on novel, less toxic kinase inhibitor drugs.

oncoinvent-logo

Oncoinvent

Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.

cadent-therapeutics-logo

Cadent Therapeutics

Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.

cerevance-logo

Cerevance

Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.

cardiol-therapeutics-logo

Cardiol Therapeutics

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

centrillion-technologies-logo

Centrillion Technologies

Centrillion Biosciences develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics.

caliber-therapeutics-logo

Caliber Therapeutics

Caliber Therapeutics offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs.

coya-therapeutics-logo

Coya Therapeutics

Coya Therapeutics is a cell therapy platform company that develops first-in-class therapeutics for ALS and other neurodegenerative diseases.

carmell-therapeutics-logo

Carmell Therapeutics

Carmell develops technology for producing biologically-active plastics from blood plasma for treating bone and connective tissue injuries.

creyon-bio-logo

Creyon Bio

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

civetta-therapeutics-logo

Civetta Therapeutics

Civetta Therapeutics is a cancer therapeutics company to advance new medicines through small molecule targeting of beta-propeller domains.

corisma-logo

Corisma

Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.

cowin-biosciences-logo

CoWin Biosciences

CoWin Biosciences provides high-quality biology reagents in life science research and molecular diagnostics field.

phoenicis-logo

Phoenicis

Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.

platelet-biogenesis-logo

Platelet BioGenesis

Platelet BioGenesis specializes in the fields of biotechnology, platelets, and drug discovery.

peptilogics-logo

Peptilogics

Clinical-stage therapeutics company with a computational deep learning peptide design platform • Design > discovery

phenovista-biosciences-logo

PhenoVista Biosciences

PhenoVista Biosciences provides high content imaging-based phenotypic assay development and screening services.

propellon-therapeutics-logo

Propellon Therapeutics

Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein.

Current Advisors List

aaron-fletcher_image

Aaron Fletcher Board Member @ Cognition Therapeutics
Board_member
2015-01-01

Current Employees Featured

anthony-o-caggiano_image

Anthony O. Caggiano
Anthony O. Caggiano Chief Medical Officer and Head of R&D @ Cognition Therapeutics
Chief Medical Officer and Head of R&D

gilbert-m-rishton_image

Gilbert M. Rishton
Gilbert M. Rishton Co-Founder, Chief Medicinal Chemistry Advisor @ Cognition Therapeutics
Co-Founder, Chief Medicinal Chemistry Advisor
2007-01-01

susan-catalano_image